Clinical study shows Xylyx Bio’s Matrikynes® significantly improves the structure, function, and appearance of skin

Xylyx Bio, a regenerative medicine company developing breakthrough technologies for organ and tissue repair, today announced findings from an independent clinical study that validated that their proprietary Matrikynes® ingredient is safe and highly effective for anti-aging and other topical skin applications. Results from the study are reported in the white paper “Clinical evaluation of Matrikynes®: a novel cosmetic ingredient comprised of matrikine peptides”. Developed through biomedical research aimed at better understanding and promoting tissue repair and wound healing, Matrikynes® is comprised of a proprietary mixture of natural extracellular matrix-derived peptides called matrikines. Read more >>